CD8A and neoplasm: Our findings demonstrate that the addition of GK-1 to BMDCs loaded with MAGE-AX decreases the rate of tumor growth and increases the survival of mice and the expression of CD86 and IL-12 in the BMDCs, as well as the levels of CD8 IFNγ producing T cells.